Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New history entries were added for Contacts/Locations, Study Design, and Study Status, along with a new version (32) and Revision: v3.3.3; the entry for HHS Vulnerability Disclosure was removed.
    Difference
    0.6%
    Check dated 2025-12-23T20:37:05.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The record shows Active, not recruiting. Added Contacts/Locations, Study Design, Study Status, and Recruitment Status sections, with revision v3.3.2 dated 2025-11-19.
    Difference
    0.6%
    Check dated 2025-11-24T21:38:55.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Notice regarding government funding lapse and operating status, previously visible on the page, has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T19:58:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    No substantive changes to the trial's record history were observed between the old and new screenshots; the version list and study data appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T13:50:39.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Major update: announces a funding-related operating status notice and a new version v3.2.0; replaces the earlier v3.1.0 release.
    Difference
    11%
    Check dated 2025-10-06T04:26:03.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T23:58:28.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.